BiomX Inc. (PHGE) Financials

PHGE Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 33.1 million 24.9 million
2023-06-30 41.3 million 25.4 million
2023-03-31 41.4 million 25.3 million
2022-12-31 45.5 million 24.5 million

PHGE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.0 million 195000
2023-06-30 -4.1 million 271000
2023-03-31 -5.1 million 175000
2022-12-31 -7.2 million 367000

PHGE Net Income

No data available :(

PHGE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 22.5 million - 3.8 million
2023-06-30 29.7 million - 4.1 million
2023-03-31 29.3 million - 4.3 million
2022-12-31 33.3 million - 4.5 million

PHGE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 60.6 million
2023-06-30 51.6 million
2023-03-31 32.1 million
2022-12-31 29.9 million

PHGE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 32000 5.6 million 2.2 million -
2023-06-30 1000 3.8 million 2.3 million -
2023-03-31 10000 4.6 million 1.6 million -
2022-12-31 32000 3.2 million 2.0 million -

PHGE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 -89000 219000
2023-06-30 -90000 217000
2023-03-31 -91000 223000
2022-12-31 -134000 624000

PHGE

Price: $0.40

52 week price:
0.19
0.86

Earnings Per Share: -0.51 USD

P/E Ratio: -0.37

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 145100

Market Capitalization: 17.3 million

Links: